Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Aug 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109409701000001119 | Cytarabine liposomal pegylated (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 109409801000001111 | Cytarabine liposomal pegylated | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cytarabine liposomal pegylated | Is a | Cytarabine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) 1 vial | Has specific active ingredient | True | Cytarabine liposomal pegylated | Inferred relationship | Existential restriction modifier | |
| DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) | Has specific active ingredient | True | Cytarabine liposomal pegylated | Inferred relationship | Existential restriction modifier | |
| Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial | Has specific active ingredient | True | Cytarabine liposomal pegylated | Inferred relationship | Existential restriction modifier | |
| Cytarabine 50mg/5ml intrathecal suspension for injection vials | Has specific active ingredient | True | Cytarabine liposomal pegylated | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR